iMM innovators

iMM Lisboa produces cutting-edge scientific research as testified by the many high-quality papers published every year in peer-reviewed international journals. It is a major objective of the iMM Direction that such outstanding research may be translated into biomedical products for the benefit of patients and society as a whole. This is a major challenge for any institution, which requires specific measures and intervention. The EU-funded project “TwinntoInfect” now allows a dedicated budget for a new program focused on innovation and technology transfer, hereby designated “iMM innovators (“iMMi”).

iMMi is aimed at supporting iMM scientists (students, technical staff and researchers, Group Leaders) to develop their ideas, technologies or projects with potential application, with the ultimate goal of commercialization. The successful development of entrepreneurial ideas requires time, money and specific skills.